Featuring an interview with Prof Sia Daneshmand, including the following topics:
- Clinical presentation and initial evaluation of non-muscle-invasive urothelial bladder cancer (NMIBC) (0:00)
- Alternative induction regimens when BCG is not available (4:06)
- Treatment options for patients with BCG-refractory disease (8:46)
- Role of immunotherapy in treating NMIBC (13:58)
- Role of cystectomy in treating NMIBC (15:47)
- Intravesical drug delivery for patients with muscle-invasive urothelial bladder cancer (MIBC) (20:37)
- Dispelling myths and misperceptions about cystectomy and counseling eligible patients (26:19)
- Neoadjuvant and adjuvant therapy for MIBC (37:40)
CME information and select publications